A29S (p.Ala29Ser) variant of GLA (Alpha-galactosidase A)
A29S (p.Ala29Ser) in GLA (Alpha-galactosidase A) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not provided; Fabry disease; Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.40 / 1. The record also includes population frequency data, published literature, and structural context.
A29S (p.Ala29Ser) variant details
- p.Ala29Ser
- rs142449183
- ClinGen CA413937480
- ClinVar RCV001187973
- ClinVar RCV001751339
- Uncertain significance
- not provided; Fabry disease; Cardiovascular phenotype
- Missense
- Variant Prioritization Score for Impact Estimate 0.404
- REVEL 0.28
- AlphaMissense 0.08
- MetaLR 0.98
- MetaSVM 1.77
- CADD 7.54
- PolyPhen-2 0.01
- ClinVar: Uncertain significance (not provided; Fabry disease; Cardiovascular phenotype)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Most common in the REMAINING population (allele frequency 2.2e-05)
- Structural context available
- Cited in: Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors. (PMID 12735292)
- Cited in: Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. (PMID 16980809)